Navigation Links
TWi Biotechnology Successfully Completes Patient Recruitment for Phase IIb Trial of AC-201 for the Treatment of Type II Diabetes
Date:9/7/2011

TAIPEI, Taiwan, Sept. 7, 2011 /PRNewswire-Asia/ -- TWi Biotechnology, Inc. announces the successful patient recruitment for the multinational, multicenter, randomized, double-blind, placebo-controlled, dose-ranging Phase IIb clinical trial of AC-201 for the treatment of Type II Diabetes. A combined 240 patients from 13 US sites plus 8 Taiwan sites have been enrolled to the trial. With six-month treatment and one-month follow-up, completion of the trial data analysis is expected in the early second quarter of 2012. The trial's primary endpoint is defined as the change in glycated hemoglobin A1c (HbA1c) from baseline compared to placebo after twenty-four weeks of treatment. In addition, the study is powered to demonstrate additional benefits by monitoring various secondary endpoints including change in lipid profile, change in body weight, change in blood pressure and change in beta-cell function. Meanwhile, by measuring various biomarkers such as interleukin-1Beta, interleukin-1 receptor antagonist, interleukin-6, tumor necrosis factor-Alpha, high-sensitivity C-reactive protein, plasminogen activator inhibitor-1, transforming growth factor-Beta, and adiponectin, the company is able to stratify different patient groups in terms of clinical response, so as to develop personalized, preventive or therapeutic strategies.

"Through careful planning and execution, we are pleased with the efficient manner in which the twenty-one clinical sites, thirteen in US and eight in Taiwan, have enrolled 240 patients in the phase IIb study within 5 months since its inception, which is 4-month ahead of the expected schedule," stated Dr. M. Sherry Ku, President & CSO of TWi Biotech. "During the previous Phase IIa study, those patients with inadequate blood glucose control by multiple drug combinations of currently available oral anti-diabetic drugs were treated with AC-201 as an add-on therapy. The Phase IIa proof-of-concept study showed a mean reduction of 0.63% for HbA1c (
'/>"/>

SOURCE TWi Biotechnology, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Industrial Biotechnology China News 1108
2. Amarantus BioSciences and Generex Biotechnology Collaborate on Cell Therapy for Late Stage Diabetes
3. Summer Street Research Announces Expansion of Research Team with the Addition of Ling Wang, CFA, Senior Biotechnology Analyst
4. Industrial Biotechnology China News 1106
5. Reportlinker Adds White Biotechnology
6. New Jersey Targets Life-Sciences Investors at Worlds Largest Biotechnology Event
7. Reportlinker Adds India Biotechnology in India Industry
8. MKM Partners Hires Biotechnology/Specialty Pharmaceuticals Analyst
9. Reportlinker Adds Industrial Biotechnology China News 1105 - Annual Subscription
10. Reportlinker Adds Future of White Biotechnology in China
11. Asmacure Ltee Appoints Pharmaceutical and Biotechnology Industry Veteran Martin Driscoll as CEO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... , May 17, 2013  Yongye International, Inc. ... a leading developer, manufacturer, and distributor of crop nutrient ... , today announced that, on May 16, 2013, ... of directors (the "Board of Directors") was provided a ... Hong Kong ) Limited ("Abax") to Full ...
(Date:5/17/2013)... The paradigm of ‘one drug, one ... can help predict the adverse and therapeutic effects of ... of Computational Biology at the Genomics Laboratory, Covance, will ... high-quality genomics when used as part of the QC ... data sets to identify key clinical targets even in ...
(Date:5/17/2013)... Darrington, WA (PRWEB) May 17, 2013 Tooth ... 5th graders showing active signs of the disease. The World ... children and nearly 100% of adults have cavities. What are ... Research is showing a strong connection between the oral ... why is this disease so rampant, yet it is also ...
(Date:5/16/2013)... Auckland, New Zealand (PRWEB) May 16, 2013 ... Zealand, was invited to speak to doctors in China about ... across Australia and NZ, this was her first trip to ... , Dr. Hart visited Guangzhou and Fuzhou, home to 12 ... treatments in China is very high at this point in ...
Breaking Biology Technology:Yongye International Provides Update on Status of Proposed Go Private Offer 2Yongye International Provides Update on Status of Proposed Go Private Offer 3Yongye International Provides Update on Status of Proposed Go Private Offer 4Seeing the Future: How a Revolutionary New Bacterial Screening Device Can Predict a Patient’s Future for Tooth Decay 2Seeing the Future: How a Revolutionary New Bacterial Screening Device Can Predict a Patient’s Future for Tooth Decay 3
... Researchers have been examining the diverse behaviours of caterpillars ... and rescue soft robots. Despite their extreme ... by their slow speed, leading the researchers to turn ... caterpillars have the extraordinary ability to rapidly curl themselves ...
... April 26, 2011 HollisterStier Allergy announced that ... president of the business, illustrating the continued investment ... Life Sciences, Ltd (Jubilant).   (Photo: ... 25 years of healthcare experience, 15 of which ...
... DIEGO, April 26, 2011 Gen-Probe Incorporated (NASDAQ: ... Deutsche Bank Securities, 26th Annual Health Care Conference in Boston ... at ThinkEquity,s 2nd Annual Health Care Conference in New York ... scheduled to be webcast live and may be accessed through ...
Cached Biology Technology:Caterpillars inspire new movements in soft robots 2Kevin Garrity Named President of HollisterStier Allergy 2Gen-Probe to Webcast Two Upcoming Investor Presentations 2
(Date:5/17/2013)... study finds human-caused climate change may have little ... a host of recent studies that predict their ... The findings, which appear in the journal ... survival of a creature thought to be doomed: ... cold-blooded animals, especially forest lizards, will be hard ...
(Date:5/16/2013)... FASEB MARC (Maximizing Access to Research Careers) Program ... Society for Developmental Biology (SDB) 72nd Annual Meeting ... awards are meant to promote the entry of ... the mainstream of the basic science community and ... the SDB 2013 Annual Meeting. , Awards are ...
(Date:5/16/2013)... The endothelium, the cellular layer lining the ... a few hundred nanometers in thickness, this super-tenuous ... and tissue compression to create a unique and ... to partition tissues from the body,s circulatory system. ... the barrier must be physically breached to ...
Breaking Biology News(10 mins):Climate change may have little impact on tropical lizards 2Endothelium, heal thyself 2Endothelium, heal thyself 3Endothelium, heal thyself 4
... As governments prepare to gather at the United Nations ... 20, a new report published by a group of ... that a combined approach to tackling poverty and diseasethat ... and nutrition/food securityachieves better results for the world,s poorest. ...
... diagnosis of disease and developmental syndromes often depends on ... onset hearing loss are genetic in origin but there ... to identify the gene responsible for the hearing loss ... among countries and populations. New research published in BioMed ...
... infected with cowpox but rarely catch smallpox is generally credited ... not have been the first person to notice the correlation, ... in 1796 he "vaccinated" children with material from cowpox blisters ... work led directly to the development of a smallpox vaccine ...
Cached Biology News:Report showcases success of integrated development approaches 2Report showcases success of integrated development approaches 3Exome sequencing: Defining hereditary deafness 2Cowpox virus: Old friend but new foe 2Cowpox virus: Old friend but new foe 3
The Hybrid Hunter Yeast Two-Hybrid System uses the activation of reporter genes to indicate positive protein-protein interactions. Two reporters are used an auxotrophic marker and lacZ....
Tris-Hepes kit of BG-163 & BG-165 (order number BG-166)...
Incorporating the innovative InGaAs detection system the Cary 6000i is the worlds most advanced UV-Vis-NIR spectrophotometer delivering superior signal to noise performance and outstanding sensitivit...
... The LAB PAL label printer is portable, easy-to-use ... efficient. Portable/Handheld Easy to use ... Pre-programmed vial and slide sizes ... Affordable-every tech needs one Serialization feature ...
Biology Products: